Eyestem Research Pvt Ltd announced positive results from its phase 1/2 trial ( NCT06394232) evaluating its investigational ...

Medtech: In the 21st century, ‘Artificial Intelligence (AI)’ is not a buzzword—it is the brain of modern medicine. As the ...

Today, advancements in medical technology have completely changed how we approach eye care. With faster, more accurate diagnoses and less invasive treatment options, modern eye hospitals are combining ...

The Ohio State Medical Association has launched "Your Care is at Our Core" campaign in partnership with the AMA to advocate ...

The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in ...

The FDA told Regeneron in a complete response letter that while it didn't identify any issues with the safety or efficacy of the drug in its approved indications and dosing regimens, the agency didn't ...

The following is a summary of “Biomarkers of ocular manifestation in newly diagnosed giant cell arteritis,” published in the April 2025 issue of BMC Ophthalmology by Terheyden et al. Giant cell ...

His research interests include diabetic retinopathy, macular degeneration, retinal vein occlusions, and infectious retinitis. He has a particular interest in retinal pharmacology, pharmacokinetics ...